Navigation Links
TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
Date:8/31/2008

Landmark ARB trial investigated Micardis(R) (telmisartan) against placebo in reducing the composite endpoint of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure in ACE inhibitor intolerant high-risk patients receiving current standard of care

RIDGEFIELD, Conn., Aug. 31 /PRNewswire/ -- The primary results of the TRANSCEND(TM)* trial demonstrated that treatment with MICARDIS(R) (telmisartan) 80mg in patients receiving current standard of care resulted in an 8% reduction in the composite endpoint of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure. This reduction was not statistically significant (p=0.216; HR 0.92) compared to patients receiving placebo in addition to current standard of care.(1) Results of the main secondary endpoint of TRANSCEND as pre-specified in the statistical plan demonstrated that telmisartan significantly reduced the risk of cardiovascular death, myocardial infarction and stroke in high-risk cardiovascular patients by 13% compared with those patients already receiving current standard of care (p=0.048).(1) This risk reduction was achieved despite a high proportion of patients receiving proven therapies such as statins, anti-platelet agents or beta blockers. The main secondary endpoint of TRANSCEND mirrors the primary endpoint of the landmark HOPE trial.(2) A post-hoc analysis to adjust for multiplicity and overlap with primary endpoint showed a p-value of 0.068.(1) The results were presented today at the annual meeting of the European Society of Cardiology in Munich, Germany and published online in The Lancet.

In high-risk patients who cannot tolerate an angiotensin-converting enzyme (ACE) inhibitor, the TRANSCEND trial was designed to investigate potential cardiovascular risk reduction benefits using the second-generation angiotensin II receptor blocker (ARB) telmisartan. Telmisartan was compared to placebo on top of
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014   Zacks Equity Research highlights Epizyme (Nasdaq: ... Day and Panera (Nasdaq: PNRA - Free Report ) as ... analysis on Amicus Therapeutics (Nasdaq: FOLD - Free Report ), ... SHPG - Free Report ). Here is a ... the Day : The biotech bull market is ...
(Date:8/22/2014)...  - MediaLINC unlocks ... Lincor announced general availability of MediaLINC - ... range of education, entertainment and clinical content direct to ... , " Lincor has already ... engagement to bedside smart devices, " comments Dan ...
(Date:8/22/2014)... Calif. , Aug. 22, 2014  WaferGen Bio-systems, ... underwritten public offering of units of common stock and ... gross proceeds of $20 million, prior to deducting underwriting ... Company.  The shares and warrants are immediately separable and ... are expected to begin trading on The NASDAQ Stock ...
Breaking Medicine Technology:Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Lincor Unveils Next Generation TV-based Patient Engagement Solution 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
... June 18 United American Healthcare Corporation (Nasdaq: ... held Pulse Systems, LLC.  Based in Concord, Calif. ... the medical device industry, with a focus on precision ... components, sub-assemblies and implants, primarily in the cardiovascular market. ...
... SHENZHEN, China , June 18 /PRNewswire-Asia-FirstCall/ ... TCM ), a leading,specialty pharmaceutical company focusing on the ... China ,today announced its financial results for the quarter ... Financial Results for the Quarter Ended March 31, 2010, ...
Cached Medicine Technology:United American Healthcare Corporation Announces Acquisition of Pulse Systems, LLC 2United American Healthcare Corporation Announces Acquisition of Pulse Systems, LLC 3United American Healthcare Corporation Announces Acquisition of Pulse Systems, LLC 4Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 2Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 3Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 4Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 5Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 6Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 7Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 8Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 9Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 10Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 11Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 12Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 13Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 14Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results 15
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a web professional ... has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) is ... GoDaddy is a popular supplier of cheap web hosting, ... at affordable rates. It offers three Linux shared hosting ... on the length of the contract. The longest contract ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 AWeber, ... marketing services that currently helps more than 120,000 ... has caught the attention of Shane Michaels, prompting an ... a crucial element for any online marketing campaign, despite ... email in the marketing world,” reports Michaels. “AWeber is ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Buying a policy ... adult who is unsure about available coverage types by insurers ... principal life insurance policy pricing to the public using its ... of this tool is free and is expected to promote ... to the public throughout the U.S. The system is designed ...
(Date:8/22/2014)... August 22, 2014 The regional economy ... Indiana is on the grow again. The ... by summer 2016 to boost production of the popular ... Toyota Indiana’s overall investment to $4 billion. This step ... while providing additional flexibility to adjust its product mix ...
(Date:8/22/2014)... York (PRWEB) August 22, 2014 ... morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in uterine surgeries continues ... Massachusetts insurance companies have decided to limit coverage ... the Worcester Telegram, Blue Cross-Blue Shield of Massachusetts ... surgeries that involve morcellation as of September 1, ...
Breaking Medicine News(10 mins):Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 4
... not increase lung cancer mortality in postmenopausal women, according ... The Journal of the National Cancer Institute. ... consisted of several clinical trials on postmenopausal women, one ... plus progestin therapy had a statistically significant increase in ...
... Gardner HealthDay Reporter , FRIDAY, Aug. 13 (HealthDay ... experts say it,s likely that the Northern Hemisphere will see ... flu season. The virus will continue to circulate, said ... Emergency Medical Preparedness and Response, but he hasn,t "seen anything ...
... HealthDay Reporter , FRIDAY, Aug. 13 (HealthDay News) -- When John ... empty bottle of ibuprofen on the living room floor -- and ... knocked the pain-reliever container off the coffee table -- where D,Amato ... the pills. "My heart dropped through the floor," he said ...
... cells from a patient,s blood or bone marrow that nourish ... to treatment of cardiovascular disease than obtaining rare stem cells, ... In recent clinical trials, doctors in several countries have tested ... damage, such as heart attacks and peripheral artery disease, created ...
... to adopt electronic medical records helps speed adoption by ... in the current issue of Management Science , ... and the Management Sciences (INFORMS)., "Social Contagion and Information ... U.S. Hospitals" is by Corey M. Angst and Ken ...
... By Madonna Behen HealthDay Reporter , THURSDAY, ... but it,s true: Parents never stop worrying about their children,s ... when parents have a mix of successful and not-so-successful adult ... isn,t offset by positive feelings from the accomplishments of their ...
Cached Medicine News:Health News:Estrogen not associated with lung cancer incidence and mortality among postmenopausal women 2Health News:Experts Predict 'Normal' H1N1 Flu Season This Year 2Health News:Human Meds Are Pets' Biggest Poisoning Danger 2Health News:Human Meds Are Pets' Biggest Poisoning Danger 3Health News:Selected cells from blood or bone marrow may provide a route to healing blood vessels 2Health News:Selected cells from blood or bone marrow may provide a route to healing blood vessels 3Health News:Speed electronic medical record adoption via key medical centers, says Management Science 2Health News:One Troubled Adult Child a Drag on Parents' Mental Health 2Health News:One Troubled Adult Child a Drag on Parents' Mental Health 3
2.5V Incandescent source, 3X magnification, pocket-sized....
... via fiber optic for homogenous ... have bright halogen illumination for ... aural canal. Lithium-ion batteries ... Ring rheostat for fine control ...
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
... Ri-scope® line offer patented Sensomatic® ... when picked up and switch ... Fiber-optic delivery of light from ... uniform illumination of examination area. ...
Medicine Products: